Analysis of the therapeutic benefits of symptomatic slow acting drugs in osteoarthritis: emphasis on structural-modifying action
The review presents an analysis of the therapeutic effect in osteoarthritis (OA) of the original complex injectable drug Alflutop (bioactive concentrate of small marine fish), which is one of the most widely used symptomatic slow acting drugs (SYSADOA) in Russia. It stimulates the proliferation of c...
Saved in:
| Main Authors: | I. B. Belyaeva, V. I. Mazurov, E. A. Trofimov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multimorbidity in osteoarthritis
by: E. A. Taskina, et al.
Published: (2022-07-01) -
The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: Accent on microcirculation parameters
by: A. S. Trofimova, et al.
Published: (2024-03-01) -
Symptom-modifying slow-acting drugs in the treatment of osteoarthritis: from molecule to clinical effect (a pharmacologist's view)
by: A. S. Dukhanin
Published: (2018-06-01) -
Alflutop in osteoarthritis therapy
by: G. V. Lukina, et al.
Published: (2004-06-01) -
Evaluation of the efficiency and safety of combined therapy with a symptomatic sustained-release drug and hyaluronic acid versus monotherapy with hyaluronic acid in patients with knee osteoarthritis
by: K. A. Berdyugin, et al.
Published: (2020-09-01)